The COMBAT Consortium is working to understand why some patients become severely ill with COVID-19. We aim to use this knowledge to help identify more effective biomarkers and support development of targeted therapies to improve outcomes for patients.
Here we provide a web tool to visualise the results of deep immune phenoytyping in peripheral blood, showing findings for patient donors with COVID-19 of varying severity and comparing with results from patients with influenza and sepsis, and with healthy donors.
For more information on COMBAT please see our preprint here, and COMBAT website
Explore differences in gene expression and protein abundance using the search function Gene and Protein Search | ||
Hallmarks COVID-19 severity COVID-19 vs influenza COVID-19 vs sepsis |
Mass cytometry (CyTOF) | Data for whole blood on 126 donors (hospitalised and community COVID-19, sepsis, and healthy). Results for non-depleted and granulocyte depleted profiling using specific CyTOF panels | Visualise cell composition | |
Transcriptomics (Total RNA-seq) | Data for whole blood on 123 donors (hospitalised and community COVID-19, sepsis, and healthy) using total RNA sequencing (23,063 features) | Visualise gene expression | |
Single cell composition (CITE-seq) | Data for peripheral blood mononuclear cells (PBMC) on 122 donors (hospitalised and community COVID-19, sepsis, influenza, and healthy) using CITEseq (multimodal cluster annotation by cell type, major and minor subsets | Visualise cell composition | |
Single cell gene expression (CITE-seq) | Single cell expression data for peripheral blood mononuclear cells (PBMC) on 122 donors (hospitalised and community COVID-19, sepsis, influenza, and healthy) using CITEseq | Visualise gene expression | |
B and T cell repertoire | Data for whole blood on 77 donors (hospitalised and community COVID-19, sepsis, and healthy) using bulk sequencing; and PBMC on 122 donors (hospitalised and community COVID-19, sepsis, influenza, and healthy) using CITEseq (multimodal cluster annotation). | Visualise repertoire | |
Proteomics (mass spectrometry) | Data for plasma on 257 donors (hospitalised and community COVID-19, sepsis, and healthy) using high throughput liquid chromatography with tandem mass spectrometry quantifying 105 proteins | Visualise protein abundance | |
Proteomics (luminex) | Data for plasma and serum on 171 and 75 donors respectively (hospitalised and community COVID-19, sepsis, influenza, and healthy) using luminex immunoassay. quantifying 51 circulating cytokine and chemokine proteins. | Visualise protein abundance |